DE69723681D1 - Verfahren zur identifizierung von mhc-class i beschränkten, durch einen zellulären sekretorischen weg endogen verarbeiteten antigenen - Google Patents

Verfahren zur identifizierung von mhc-class i beschränkten, durch einen zellulären sekretorischen weg endogen verarbeiteten antigenen

Info

Publication number
DE69723681D1
DE69723681D1 DE69723681T DE69723681T DE69723681D1 DE 69723681 D1 DE69723681 D1 DE 69723681D1 DE 69723681 T DE69723681 T DE 69723681T DE 69723681 T DE69723681 T DE 69723681T DE 69723681 D1 DE69723681 D1 DE 69723681D1
Authority
DE
Germany
Prior art keywords
mhc class
antigen
cellular
secretory pathway
secretoral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69723681T
Other languages
English (en)
Other versions
DE69723681T2 (de
Inventor
A Jefferies
Reinhard Gabathuler
Gerassimos Kolaitis
S Reid
Judie Alimonti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of British Columbia
Original Assignee
University of British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of British Columbia filed Critical University of British Columbia
Application granted granted Critical
Publication of DE69723681D1 publication Critical patent/DE69723681D1/de
Publication of DE69723681T2 publication Critical patent/DE69723681T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
DE69723681T 1996-03-12 1997-03-12 Verfahren zur identifizierung von mhc-class i beschränkten, durch einen zellulären sekretorischen weg endogen verarbeiteten antigenen Expired - Lifetime DE69723681T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/614,142 US5792604A (en) 1996-03-12 1996-03-12 Method of identifying MHC-class I restricted antigens endogenously processed by cellular secretory pathway
US614142 1996-03-12
PCT/CA1997/000173 WO1997034143A1 (en) 1996-03-12 1997-03-12 Method of identifying mhc-class i restriced antigens endogenously processed by a cellular secretory pathway

Publications (2)

Publication Number Publication Date
DE69723681D1 true DE69723681D1 (de) 2003-08-28
DE69723681T2 DE69723681T2 (de) 2004-07-08

Family

ID=24460024

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69723681T Expired - Lifetime DE69723681T2 (de) 1996-03-12 1997-03-12 Verfahren zur identifizierung von mhc-class i beschränkten, durch einen zellulären sekretorischen weg endogen verarbeiteten antigenen

Country Status (8)

Country Link
US (1) US5792604A (de)
EP (1) EP0888540B1 (de)
JP (1) JP3805792B2 (de)
AT (1) ATE245815T1 (de)
AU (1) AU2088997A (de)
CA (1) CA2248651C (de)
DE (1) DE69723681T2 (de)
WO (1) WO1997034143A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6872518B2 (en) 1997-09-22 2005-03-29 University Of Rochester Methods for selecting polynucleotides encoding T cell epitopes
EP1137769B1 (de) * 1998-11-10 2008-09-03 University Of Rochester Methoden zu herstellung von genbanken
EP1214407A2 (de) * 1999-09-21 2002-06-19 GSF-Forschungszentrum für Umwelt und Gesundheit GmbH Verfahren zur identifizierung von mhc-restringierten antigenen
US7084256B2 (en) * 1999-09-24 2006-08-01 Large Scale Biology Corporation Self antigen vaccines for treating B cell lymphomas and other cancers
US20030044420A1 (en) * 1999-09-24 2003-03-06 Mccormick Alison A. Self antigen vaccines for treating B cell lymphomas and other cancers
EP1268763A2 (de) 2000-03-28 2003-01-02 University Of Rochester Verfahren zur herstellung einer bibliothek und zur selektion von polynukleotiden
AU2012216792A1 (en) 2011-09-12 2013-03-28 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
US9347065B2 (en) 2012-03-29 2016-05-24 International Aids Vaccine Initiative Methods to improve vector expression and genetic stability

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283058A (en) * 1990-08-30 1994-02-01 The General Hospital Corporation Methods for inhibiting rejection of transplanted tissue
WO1992011289A1 (en) * 1990-12-19 1992-07-09 Imperial Cancer Research Technology Ltd. Antigen processing
US5252224A (en) * 1991-06-28 1993-10-12 Modell Development Corporation Supercritical water oxidation process of organics with inorganics
CA2114647A1 (en) * 1991-08-02 1993-02-18 Denise Faustman Diagnosis and treatment of autoimmune diseases
US6361770B1 (en) * 1994-09-23 2002-03-26 University Of British Columbia Method of enhancing expression of MHC class I molecules bearing endogenous peptides

Also Published As

Publication number Publication date
US5792604A (en) 1998-08-11
CA2248651A1 (en) 1997-09-18
DE69723681T2 (de) 2004-07-08
CA2248651C (en) 2004-09-07
ATE245815T1 (de) 2003-08-15
EP0888540A1 (de) 1999-01-07
WO1997034143A1 (en) 1997-09-18
EP0888540B1 (de) 2003-07-23
JP2000506973A (ja) 2000-06-06
AU2088997A (en) 1997-10-01
JP3805792B2 (ja) 2006-08-09

Similar Documents

Publication Publication Date Title
Butcher et al. Direct fluorescent labeling of cells with fluorescein or rhodamine isothiocyanate. I. Technical aspects
Hogan et al. Isolation of a human teratoma cell line which expresses F9 antigen
Law et al. Action of the C3b-inactivator on cell-bound C3b
DK0815257T3 (da) Fremgangsmåde til karakterisering af biologisk aktive stoffer
ATE238550T1 (de) Markierung und auswahl von molekülen
KR870005249A (ko) 세포개체군 또는 아군집의 정량
KR950704475A (ko) 분비 생성물에 의한 직접적인 세포 선별(direct selection of cells by se-cretion product)
EA199800992A1 (ru) Катионные виросомы в качестве системы для переноса генетического материала
DE69723681D1 (de) Verfahren zur identifizierung von mhc-class i beschränkten, durch einen zellulären sekretorischen weg endogen verarbeiteten antigenen
US5637465A (en) Method for the detection of a programmed or induced cell death of eukaryotic cells
CA2489212A1 (en) Marker for stem cells and its use
DK478481A (da) Testmateriale til bestemmelse af en ligand i eller ligandbindingskapaciteten af en flydende proeve dets fremstilling og anvendelse
NZ595791A (en) High throughput assay systems and methods for identifying agents that alter expression of cellular proteins
ATE132896T1 (de) Methoden zur verwendung von an humanen klasse-ii- histokompatibilitätsantigenen mangelnden zellinien
CO5300499A1 (es) Ensayo de inmunoabsorbente ligado a enzima de inhibicion (elisa) para deteccion y cuantificacion de anticuerpos en muestras biologicas
Modak et al. An enzymatic assay for DNA in epoxy-tissue-sections by light microscope-autoradiography
AU4567501A (en) Novel g-protein coupled receptors
FR2423541A1 (fr) Procede de tri parmi une population de micro-organismes, notamment de bacteries, de ceux qui sont porteurs ou producteurs d'un constituant intracellulaire particulier, notamment d'un fragment d'acide nucleique determine
Watson et al. A membrane form of estrogen receptor-α mediates estrogenic, nongenomic effects
Westin Immunological studies on the incorporation of radioactive leucine into sea urchin embryonic proteins: extractability and turn-over of newly synthesized proteins
Burchanowski et al. In ‘undifferentiated’PC12 cells, GERL is not segregated from the Golgi apparatus
PT901632E (pt) Processo citofluorometrico para a determinacao no soro de anticorpos contra antigenios tumorais
Coosemans et al. Partial characterization of different cell types found in the Xenopuslaevis lymphoreticular tumor based on the presence or absence of surface immunoglobulins and Fc receptor molecules
HERCHER et al. Rapid identification of micro-organisms(Final Report, 5 Apr. 1982- 31 May 1985)
ES2125260T3 (es) Elementos y procedimientos que utilizan agentes de amplificacion de superficie polimericos.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition